21 Jul, 2024
2 mins read

Zuranolone: Biogen and Sage Obtain FDA Approval for Postpartum Depression Pill

The Food and Drug Administration of the United States has given approval to the first medication designed to treat postpartum depression. Biogen (BIIB) and Sage Therapeutics (SAGE) co-developed the medication. The approval had varied results for the businesses. It was not licensed for the treatment of major depressive disorder, which could have made it more […]